1. Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.
- Author
-
Silva-Fernández, Lucía, Otón, Teresa, Askanase, Anca, Carreira, Patricia, López-Longo, Francisco Javier, Olivé, Alejandro, Rúa-Figueroa, Íñigo, Narváez, Javier, Ruiz-Lucea, Esther, Andrés, Mariano, Calvo, Enrique, Toyos, Francisco, Alegre-Sancho, Juan José, Tomero, Eva, Montilla, Carlos, Zea, Antonio, Uriarte, Esther, Calvo-Alén, Jaime, Marras, Carlos, and Martínez-Taboada, Víctor M.
- Subjects
- *
LUPUS nephritis , *NEPHROTIC syndrome , *PROGNOSIS , *HEALTH insurance - Abstract
Abstract Objectives The course and long-term outcome of pure membranous lupus nephritis (MLN) are little understood. The aims of this study are to evaluate the clinical features, course, outcome and prognostic indicators in pure MLN and to determine the impact of ethnicity and the type of health insurance on the course and prognosis of pure MLN. Methods We conducted a retrospective review of medical records of 150 patients with pure MLN from Spain and the USA. Results Mean age was 34.2 ± 12.5 and 80% were women. Sixty-eight percent of patients had nephrotic syndrome at diagnosis. The average serum creatinine was 0.98 ± 0.78 mg/dl. Six percent of patients died and 5.3% developed end-stage renal disease (ESRD). ESRD was predicted by male sex, hypertension, dyslipidemia, high basal 24 h-proteinuria, high basal serum creatinine and a low basal creatinine clearance. Age, cardiac insufficiency, peripheral artheriopathy, hemodialysis and not having received mycophenolate mofetil or antimalarials for MLN predicted death. Conclusions Pure MLN frequently presents with nephrotic syndrome, high proteinuria and normal serum creatinine. Its prognosis is favourable in maintaining renal function although proteinuria usually persists over time. Baseline cardiovascular disease and not having a health insurance are related with poor prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF